New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised); clotrimazole 1%; clotrimazole 1%{relative} - combination - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: clotrimazole 1% excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canestan clotrimazole thrush 1 day pessary & cream is indicated for the topical treatment of vulvovaginal candidiasis. the cream can also be used in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised) - pessary - 500 mg - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - canesten clotrimazole thrush 1 day pessary and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised) - pessary - 500 mg - active: clotrimazole 500mg (micronised) excipient: gelatin glycerol liquid paraffin purified water quinoline yellow sunset yellow fcf titanium dioxide white soft paraffin - canesten clotrimazole thrush treatment once and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised); clotrimazole 10 mg/g - combination - active: clotrimazole 500mg (micronised) excipient: gelatin glycerol liquid paraffin purified water quinoline yellow sunset yellow fcf titanium dioxide white soft paraffin active: clotrimazole 10 mg/g excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once pessary + cream is indicated for the topical treatment of vulvovaginal candidiasis. the cream can also be used in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 100mg (micronised) - pessary - 100 mg - active: clotrimazole 100mg (micronised) excipient: calcium lactate, hydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - canesten clotrimazole thrush treatment once and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 10%{relative} (micronised ) - vaginal cream - 10 % - active: clotrimazole 10%{relative} (micronised ) excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate isopropyl myristate polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

eg labo - laboratoires eurogenerics - clotrimazole 1 - crème - 1,0 g - pour 100 g de crème > clotrimazole 1,0 g - classe pharmacothérapeutique - classe pharmacothérapeutique - code atc : antifongique local (g : système génito-urinaire et hormones sexuelles).ce médicament est indiqué dans le traitement des atteintes vulvaires des mycoses vulvo-vaginales à levures sensibles (affections dues à des champignons microscopiques).ce médicament est réservé à l’adulte.vous devez vous adresser à votre médecin si vous ne ressentez aucune amélioration ou si vous vous sentez moins bien après 7 jours .

USA - engelsk - NLM (National Library of Medicine)

proficient rx lp - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream in the treatment of infections caused by microsporum canis have been reported clotrimazole and betamethasone dipropionate cream is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or i

USA - engelsk - NLM (National Library of Medicine)

hikma pharmacuticals usa usa inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg - clotrimazole is indicated for the local treatment of oropharyngeal candidiasis. the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole is also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole is contraindicated in patients who are hypersensitive to any of its components. no data available.

USA - engelsk - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 ml - clotrimazole and betamethasone dipropionate lotion is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate lotion for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. clotrimazole and betamethasone dipropionate lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or imidazoles, or to any ingredient in these preparations.